Purine nucleotide phosphorylase

Compound 25 (Fig. 18.9), a prodrug of 9-P-D-arabinofuranosyl guanine (26), was developed for the potential treatment of leukemia. Compound 24 is poorly soluble in water and its synthesis by conventional techniques is difficult. An enzymatic demethoxylation process was developed using adenosine deaminase (Mahmoudian et al., 1999, 2001). Compound 25 was enzymatically prepared from 6-methoxyguanine (27) and ara-uracil (28) using uridine phosphorylase and purine nucleotide phosphorylase. Each protein was cloned and overexpressed in independent Escherichia coli strains. Fermentation conditions were optimized for production of both enzymes and a co-immobilized enzyme preparation was used in the biotransformation process at 200 g/L substrate input. Enzyme was recovered at the end of the reaction by filtration and reused in several cycles. A more water soluble 5 -acetate ester of compound 26 was subsequently prepared by an enzymatic acylation process using immobilized Candida antarctica lipase in 1,4-dioxane (100 g/L substrate) with vinyl acetate as the acyl donor (Krenitsky et al., 1992). 

Radabaugh, T.R., Sampayo-Reyes, A., Zakharyan, R.A., Aposhian, H.V. (2002). Arsenate reductase II. Purine nucleotide phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15 692-8. 

Note PNP = Purine Nucleotide Phosphorylase HGPRT = Hypoxanthine-Guanine Phosphoribosyl Transferase... 

At very low values of EC, when AMP is elevated it is deaminated via AMP deaminase to inosine monophosphate (IMP). This further displaces the adenylate kinase reaction in the direction of ATP synthesis. The IMP is dephosphorylated by nucleotide phosphatase, and the inosine is phosphorylyzed via purine nucleotide phosphorylase, releasing hypoxanthine and ribose 1-phosphate. The latter is metabolized via the pentose phosphate pathway, and most of the carbon atoms enter glycolysis. Because this course of events depletes the overall adenine nucleotide pool, and hence the scope for ATP production in the longer term, it represents a metabolic last ditch stand by the cell to extract energy even from the energy currency itself ... 

The base is directly ribosylated with PRPP by PT. The two enzymes concerned with purine salvage are adenine phosphoribosyl transferase (APRT), which catalyzes the formation of AMP, and hypoxanthine-guanine phosphoribosyl transferase (HGPRT), which catalyzes the formation of GMP as well as IMP, the precursor of GMP and AMP (Figure 6.58). Purine nucleotide phosphorylases (PNPases) can also... 

After purine nucleotides have been converted to the corresponding nucleosides by 5 -nucleotidases and by phosphatases, inosine and guanosine are readily cleaved to the nucleobase and ribose-1-phosphate by the widely distributed purine nucleoside phosphorylase. The corresponding deoxynucleosides yield deoxyribose- 1-phosphate and base with the phosphorylase from most sources. Adenosine and deoxyadenosine are not attacked by the phosphorylase of mammalian tissue, but much AMP is converted to IMP by an aminohydrolase (deaminase), which is very active in muscle and other tissues (fig. 23.20). An inherited deficiency of purine nucleoside phosphorylase is associated with a deficiency in the cellular type of immunity. 

Melki, R., Fievez, S., and Carlier, M.-F. (1996). Continuous monitoring of Pi release following nucleotide hydrolysis in actin or tubulin assembly using 2-amino-6-mer-capto-7-methylpurine ribonucleoside and purine-nucleoside phosphorylase as an enzyme-linked assay. Biochemistry 35, 12038-12045. 

In addition, many examples of binding systems were investigated by stopped-flow fluorescence spectroscopy, such as the binding of calmodulin to calcineuiin, the binding of guanine to calf spleen purine nucleoside phosphorylase, the nucleotide cofactor binding to the Escherichia coli PriA Helicase, etc. 

Similarly a deficiency of Purine Nucleoside Phosphorylase causes accumulation of dGTP. In both cases Ribonucleotide Reductase is inhibited by accumulation of these nucleotides. 

To identify motifs that are effective for the inhibition of human purine nucleoside phosphorylase, Shibuya et al. have prepared numerous conforma-tionally restricted nucleotides (30) and (31) that act as multi-substrate analogue inhibitors for Preliminary results demonstrated that... 

Catabolism of the nucleotides (Figure 24-3, B) begins with removal of their ribose-linked phosphate, a process catalyzed by purine 5 -nucleotidase. Removal of the ribose moiety of inosine and guanosine by the action of purine-nucleoside phosphorylase forms hypoxanthine and guanine, both of which are converted to xanthme. Xanthine is converted to uric acid through the action of xanthine oxidase. 

In purine nucleoside phosphorylase deficiency, levels of purine nucleotides are high and synthesis of uric acid decreases. High levels of dGTP are apparently responsible for the impairment of T cells that is characteristic of this malady. 

Several classes of enzyme degrade nucleic acids nucleases, phosphodiesterases, nucleotidases, nuclioside phosphorylases, and nucleosidases. The bases of purine nucleotides are degraded to form the nitrogenous waste product uric acid. 

Several other purine nucleotide derivatives with alkyl halide substituents have appeared in the literature, including adenosine S -chloromethane phosphonate, adenosine 5 -chloromethylpyrophosphate, and adenosine 5 -()8-bromoethane phosphonate) (287-291). These compounds have been evaluated as affinity labels of such nucleotide-binding enzymes as leucyl- and tryptophanyl-tRNA synthetases (leucine- and tryptophan-tRNA ligases), phosphorylase b, and cAMP-... 

Muscle glycogen phosphorylase is a genetically distinct isoenzyme of liver glycogen phosphorylase and contains an amino acid sequence that has a purine nucleotide... 

The overall picture of salvage is shown in Figure 41.10. The pathways allow free bases, nucleosides, and nucleotides to be easily interconverted. The major enzymes required are purine nucleoside phosphorylase, phosphoribosyl transferases, and deaminases. 

Fig. 41.10. Salvage of bases. The purine bases hypoxanthine and gnanine react with PRPP to form the nucleotides inosine and gnanosine monophosphate, respectively. The enzyme that catalyzes the reaction is hypoxanthine-gnanine phosphoribosyltransferase (HGPRT). Adenine forms AMP in a reaction catalyzed by adenine phosphoribosyltransferase (APRT). Nucleotides are converted to nucleosides by 5 -nucleotidase. Free bases are generated from nncleosides by purine nucleoside phosphorylase. Deamination of the base adenine occurs with AMP and adenosine deaminase. Of the purines, only adenosine can be directly phosphorylated back to a nucleotide, by adenosine kinase.

Adenosine and AMP can be deaminated by adenosine deaminase and AMP deaminase, respectively, to form inosine and IMP (see Fig. 41.10). Adenosine is also the only nucleoside to be directly phosphorylated to a nucleotide by adenosine kinase. Guanosine and inosine must be converted to free bases by purine nucleoside phosphorylase before they can be converted to nucleotides by HGPRT. 

The degradation of the purine nucleotides (AMP and GMP) occurs mainly in the liver (Fig. 41.19). Salvage enzymes are used for most of these reactions. AMP is first deaminated to produce IMP (AMP deaminase). Then IMP and GMP are dephosphorylated (5 -nucleotidase), and the ribose is cleaved from the base by purine nucleoside phosphorylase. Hypoxanthine, the base produced by cleavage of IMP, is converted by xanthine oxidase to xanthine, and guanine is deaminated by... 

---